{"transactions":[{"id":818796,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":54171,"kind":"person","name":"Karp Daniel","position":1,"cik":"0001744046","reported_name":"Karp Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP, Corp. Dev."}}],"security":"Restricted Stock Units","published_at":"2026-04-02T16:17:14.000Z","date":"2026-03-31","kind":"exercise","planned":false,"acquired":false,"shares":6715,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one share of Organon common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On March 31, 2025, the Reporting Person was granted 20,147 RSUs. One-third of such RSUs vested on March 31, 2026, with the remaining two-thirds to vest on March 31, 2027 and March 31, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On March 31, 2025, the Reporting Person was granted 20,147 RSUs. One-third of such RSUs vested on March 31, 2026, with the remaining two-thirds to vest on March 31, 2027 and March 31, 2028."}],"balance_after":13432,"derivative":{"underlying":"Common Stock","underlying_shares":6715},"source":{"system":"sec-edgar","filing":"0001628280-26-023180","document":"wk-form4_1775161029.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1744046/000162828026023180/wk-form4_1775161029.xml","form_type":"4"}},{"id":818795,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":54171,"kind":"person","name":"Karp Daniel","position":1,"cik":"0001744046","reported_name":"Karp Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP, Corp. Dev."}}],"security":"Restricted Stock Units","published_at":"2026-04-02T16:17:14.000Z","date":"2026-03-31","kind":"exercise","planned":false,"acquired":false,"shares":11338,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one share of Organon common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On March 31, 2023, the Reporting Person was granted 34,014 RSUs. Two-thirds of such RSUs previously vested, and the remaining one-third vested on March 31, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On March 31, 2023, the Reporting Person was granted 34,014 RSUs. Two-thirds of such RSUs previously vested, and the remaining one-third vested on March 31, 2026."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":11338},"source":{"system":"sec-edgar","filing":"0001628280-26-023180","document":"wk-form4_1775161029.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1744046/000162828026023180/wk-form4_1775161029.xml","form_type":"4"}},{"id":818794,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":54171,"kind":"person","name":"Karp Daniel","position":1,"cik":"0001744046","reported_name":"Karp Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP, Corp. Dev."}}],"security":"Restricted Stock Units","published_at":"2026-04-02T16:17:14.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":100166,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"On March 31, 2026, the Reporting Person was granted 100,166 RSUs, with each RSU representing a contingent right to receive one share of Organon common stock. These RSUs will vest and become exercisable in three equal installments on March 31, 2027, March 31, 2028, and March 31, 2029."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On March 31, 2026, the Reporting Person was granted 100,166 RSUs, with each RSU representing a contingent right to receive one share of Organon common stock. These RSUs will vest and become exercisable in three equal installments on March 31, 2027, March 31, 2028, and March 31, 2029."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On March 31, 2026, the Reporting Person was granted 100,166 RSUs, with each RSU representing a contingent right to receive one share of Organon common stock. These RSUs will vest and become exercisable in three equal installments on March 31, 2027, March 31, 2028, and March 31, 2029."}],"balance_after":100166,"derivative":{"underlying":"Common Stock","underlying_shares":100166},"source":{"system":"sec-edgar","filing":"0001628280-26-023180","document":"wk-form4_1775161029.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1744046/000162828026023180/wk-form4_1775161029.xml","form_type":"4"}},{"id":818793,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":54171,"kind":"person","name":"Karp Daniel","position":1,"cik":"0001744046","reported_name":"Karp Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP, Corp. Dev."}}],"security":"Common Stock","published_at":"2026-04-02T16:17:14.000Z","date":"2026-03-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":2105,"price":5.7,"value":11998.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price is the closing market price of Organon & Co. (\"Organon\") common stock on Monday, March 30, 2026, as required by the plan under which the Restricted Stock Units (\"RSU\") were awarded."}],"balance_after":69547.923,"source":{"system":"sec-edgar","filing":"0001628280-26-023180","document":"wk-form4_1775161029.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1744046/000162828026023180/wk-form4_1775161029.xml","form_type":"4"}},{"id":818792,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":54171,"kind":"person","name":"Karp Daniel","position":1,"cik":"0001744046","reported_name":"Karp Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP, Corp. Dev."}}],"security":"Common Stock","published_at":"2026-04-02T16:17:14.000Z","date":"2026-03-31","kind":"exercise","planned":false,"acquired":true,"shares":6715,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":71652.923,"source":{"system":"sec-edgar","filing":"0001628280-26-023180","document":"wk-form4_1775161029.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1744046/000162828026023180/wk-form4_1775161029.xml","form_type":"4"}},{"id":818791,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":54171,"kind":"person","name":"Karp Daniel","position":1,"cik":"0001744046","reported_name":"Karp Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP, Corp. Dev."}}],"security":"Common Stock","published_at":"2026-04-02T16:17:14.000Z","date":"2026-03-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":3554,"price":5.7,"value":20257.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price is the closing market price of Organon & Co. (\"Organon\") common stock on Monday, March 30, 2026, as required by the plan under which the Restricted Stock Units (\"RSU\") were awarded."}],"balance_after":64937.923,"source":{"system":"sec-edgar","filing":"0001628280-26-023180","document":"wk-form4_1775161029.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1744046/000162828026023180/wk-form4_1775161029.xml","form_type":"4"}},{"id":818790,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":54171,"kind":"person","name":"Karp Daniel","position":1,"cik":"0001744046","reported_name":"Karp Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP, Corp. Dev."}}],"security":"Common Stock","published_at":"2026-04-02T16:17:14.000Z","date":"2026-03-31","kind":"exercise","planned":false,"acquired":true,"shares":11338,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":68491.923,"source":{"system":"sec-edgar","filing":"0001628280-26-023180","document":"wk-form4_1775161029.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1744046/000162828026023180/wk-form4_1775161029.xml","form_type":"4"}},{"id":823890,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":54171,"kind":"person","name":"Karp Daniel","position":1,"cik":"0001744046","reported_name":"Karp Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP, Corp. Dev."}}],"security":"Restricted Stock Units","published_at":"2026-03-31T16:14:23.000Z","date":"2026-03-29","kind":"exercise","planned":false,"acquired":false,"shares":14184,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU converts into one share of Organon common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These RSUs vest and are distributed as shares of Organon common stock in three equal installments on March 29, 2025, March 29, 2026, and March 29, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"These RSUs vest and are distributed as shares of Organon common stock in three equal installments on March 29, 2025, March 29, 2026, and March 29, 2027."}],"balance_after":14185,"derivative":{"underlying":"Common Stock","underlying_shares":14184},"source":{"system":"sec-edgar","filing":"0001628280-26-022415","document":"wk-form4_1774988059.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1744046/000162828026022415/wk-form4_1774988059.xml","form_type":"4"}},{"id":823889,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":54171,"kind":"person","name":"Karp Daniel","position":1,"cik":"0001744046","reported_name":"Karp Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP, Corp. Dev."}}],"security":"Common Stock","published_at":"2026-03-31T16:14:23.000Z","date":"2026-03-29","kind":"tax_withholding","planned":false,"acquired":false,"shares":4446,"price":5.84,"value":25964.64,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This price is the closing market price of Organon & Co. (\"Organon\") common stock on Friday, March 27, 2026, as required by the plan under which the Restricted Stock Units (\"RSU\") were awarded."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes the addition of 746.463 shares of Organon common stock acquired from dividend equivalents net of withholding tax not previously required to be reported."}],"balance_after":57153.923,"source":{"system":"sec-edgar","filing":"0001628280-26-022415","document":"wk-form4_1774988059.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1744046/000162828026022415/wk-form4_1774988059.xml","form_type":"4"}},{"id":823888,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":54171,"kind":"person","name":"Karp Daniel","position":1,"cik":"0001744046","reported_name":"Karp Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP, Corp. Dev."}}],"security":"Common Stock","published_at":"2026-03-31T16:14:23.000Z","date":"2026-03-29","kind":"exercise","planned":false,"acquired":true,"shares":14184,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":60853.46,"source":{"system":"sec-edgar","filing":"0001628280-26-022415","document":"wk-form4_1774988059.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1744046/000162828026022415/wk-form4_1774988059.xml","form_type":"4"}},{"id":1155865,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":54171,"kind":"person","name":"Karp Daniel","position":1,"cik":"0001744046","reported_name":"Karp Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP, Corp. Dev."}}],"security":"Common Stock","published_at":"2025-05-07T12:09:34.000Z","date":"2025-05-06","kind":"purchase","planned":false,"acquired":true,"shares":3500,"price":8.2366,"value":28828.1,"ownership":{"direct":true},"balance_after":46669.46,"source":{"system":"sec-edgar","filing":"0001821825-25-000029","document":"wk-form4_1746634167.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1744046/000182182525000029/wk-form4_1746634167.xml","form_type":"4"}},{"id":1182418,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":54171,"kind":"person","name":"Karp Daniel","position":1,"cik":"0001744046","reported_name":"Karp Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP, Corp. Dev."}}],"security":"Restricted Stock Units","published_at":"2025-04-02T17:44:06.000Z","date":"2025-03-31","kind":"exercise","planned":false,"acquired":false,"shares":4294,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU converts into one share of Organon common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"On March 31, 2022, RSUs were awarded and on March 31, 2025, the final third of these RSUs vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"On March 31, 2022, RSUs were awarded and on March 31, 2025, the final third of these RSUs vested."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4294},"source":{"system":"sec-edgar","filing":"0001821825-25-000018","document":"wk-form4_1743630240.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1744046/000182182525000018/wk-form4_1743630240.xml","form_type":"4"}},{"id":1182417,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":54171,"kind":"person","name":"Karp Daniel","position":1,"cik":"0001744046","reported_name":"Karp Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP, Corp. Dev."}}],"security":"Restricted Stock Units","published_at":"2025-04-02T17:44:06.000Z","date":"2025-03-31","kind":"exercise","planned":false,"acquired":false,"shares":4861,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU converts into one share of Organon common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"On November 7, 2022, RSUs were awarded and on March 31, 2025, the final third of these RSUs vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"On November 7, 2022, RSUs were awarded and on March 31, 2025, the final third of these RSUs vested."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4861},"source":{"system":"sec-edgar","filing":"0001821825-25-000018","document":"wk-form4_1743630240.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1744046/000182182525000018/wk-form4_1743630240.xml","form_type":"4"}},{"id":1182416,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":54171,"kind":"person","name":"Karp Daniel","position":1,"cik":"0001744046","reported_name":"Karp Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP, Corp. Dev."}}],"security":"Restricted Stock Units","published_at":"2025-04-02T17:44:06.000Z","date":"2025-03-31","kind":"exercise","planned":false,"acquired":false,"shares":11338,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU converts into one share of Organon common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On March 31, 2023, RSUs were awarded and on March 31, 2025, one-third of these RSUs vested with the remaining RSUs to vest on March 31, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"On March 31, 2023, RSUs were awarded and on March 31, 2025, one-third of these RSUs vested with the remaining RSUs to vest on March 31, 2026."}],"balance_after":11338,"derivative":{"underlying":"Common Stock","underlying_shares":11338},"source":{"system":"sec-edgar","filing":"0001821825-25-000018","document":"wk-form4_1743630240.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1744046/000182182525000018/wk-form4_1743630240.xml","form_type":"4"}},{"id":1182415,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":54171,"kind":"person","name":"Karp Daniel","position":1,"cik":"0001744046","reported_name":"Karp Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP, Corp. Dev."}}],"security":"Restricted Stock Units","published_at":"2025-04-02T17:44:06.000Z","date":"2025-03-31","kind":"exercise","planned":false,"acquired":false,"shares":14184,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU converts into one share of Organon common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On March 29, 2024, RSUs were granted and on March 29, 2025, one-third of these RSUs vested, with the remaining RSUs to vest on March 29, 2026, and March 29, 2027. Since the first anniversary of the date of grant was on Saturday, March 29, 2025, the vesting occurred on Monday, March 31, 2025, the next business day."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On March 29, 2024, RSUs were granted and on March 29, 2025, one-third of these RSUs vested, with the remaining RSUs to vest on March 29, 2026, and March 29, 2027. Since the first anniversary of the date of grant was on Saturday, March 29, 2025, the vesting occurred on Monday, March 31, 2025, the next business day."}],"balance_after":28369,"derivative":{"underlying":"Common Stock","underlying_shares":14184},"source":{"system":"sec-edgar","filing":"0001821825-25-000018","document":"wk-form4_1743630240.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1744046/000182182525000018/wk-form4_1743630240.xml","form_type":"4"}},{"id":1182414,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":54171,"kind":"person","name":"Karp Daniel","position":1,"cik":"0001744046","reported_name":"Karp Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP, Corp. Dev."}}],"security":"Restricted Stock Units","published_at":"2025-04-02T17:44:06.000Z","date":"2025-03-31","kind":"grant","planned":false,"acquired":true,"shares":20147,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU converts into one share of Organon common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Reporting Person was granted RSUs, which represent a contingent right to receive one share of Organon common stock for each RSU. On March 31, 2025, RSUs were granted and will vest in three equal installments on each of March 31, 2026, March 31, 2027, and March 31, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Reporting Person was granted RSUs, which represent a contingent right to receive one share of Organon common stock for each RSU. On March 31, 2025, RSUs were granted and will vest in three equal installments on each of March 31, 2026, March 31, 2027, and March 31, 2028."}],"balance_after":20147,"derivative":{"underlying":"Common Stock","underlying_shares":20147},"source":{"system":"sec-edgar","filing":"0001821825-25-000018","document":"wk-form4_1743630240.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1744046/000182182525000018/wk-form4_1743630240.xml","form_type":"4"}},{"id":1182413,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":54171,"kind":"person","name":"Karp Daniel","position":1,"cik":"0001744046","reported_name":"Karp Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP, Corp. Dev."}}],"security":"Stock Option (right to buy)","published_at":"2025-04-02T17:44:06.000Z","date":"2025-03-31","kind":"grant","planned":false,"acquired":true,"shares":99009,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Reporting Person was granted stock options, which vest and become exercisable in three equal installments on March 31, 2026, March 31, 2027, and March 31, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Reporting Person was granted stock options, which vest and become exercisable in three equal installments on March 31, 2026, March 31, 2027, and March 31, 2028."}],"balance_after":99009,"derivative":{"exercise_price":14.89,"underlying":"Common Stock","underlying_shares":99009},"source":{"system":"sec-edgar","filing":"0001821825-25-000018","document":"wk-form4_1743630240.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1744046/000182182525000018/wk-form4_1743630240.xml","form_type":"4"}},{"id":1182412,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":54171,"kind":"person","name":"Karp Daniel","position":1,"cik":"0001744046","reported_name":"Karp Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP, Corp. Dev."}}],"security":"Common Stock","published_at":"2025-04-02T17:44:06.000Z","date":"2025-03-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":1346,"price":14.51,"value":19530.46,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This price is the closing market price of Organon & Co. (\"Organon\") common stock on Friday, March 28, 2025, as required by the plan under which the Restricted Stock Units (\"RSU\") were awarded."}],"balance_after":43169.46,"source":{"system":"sec-edgar","filing":"0001821825-25-000018","document":"wk-form4_1743630240.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1744046/000182182525000018/wk-form4_1743630240.xml","form_type":"4"}},{"id":1182411,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":54171,"kind":"person","name":"Karp Daniel","position":1,"cik":"0001744046","reported_name":"Karp Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP, Corp. Dev."}}],"security":"Common Stock","published_at":"2025-04-02T17:44:06.000Z","date":"2025-03-31","kind":"exercise","planned":false,"acquired":true,"shares":4294,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":44515.46,"source":{"system":"sec-edgar","filing":"0001821825-25-000018","document":"wk-form4_1743630240.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1744046/000182182525000018/wk-form4_1743630240.xml","form_type":"4"}},{"id":1182410,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":54171,"kind":"person","name":"Karp Daniel","position":1,"cik":"0001744046","reported_name":"Karp Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP, Corp. Dev."}}],"security":"Common Stock","published_at":"2025-04-02T17:44:06.000Z","date":"2025-03-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":1524,"price":14.51,"value":22113.24,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This price is the closing market price of Organon & Co. (\"Organon\") common stock on Friday, March 28, 2025, as required by the plan under which the Restricted Stock Units (\"RSU\") were awarded."}],"balance_after":40221.46,"source":{"system":"sec-edgar","filing":"0001821825-25-000018","document":"wk-form4_1743630240.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1744046/000182182525000018/wk-form4_1743630240.xml","form_type":"4"}},{"id":1182409,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":54171,"kind":"person","name":"Karp Daniel","position":1,"cik":"0001744046","reported_name":"Karp Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP, Corp. Dev."}}],"security":"Common Stock","published_at":"2025-04-02T17:44:06.000Z","date":"2025-03-31","kind":"exercise","planned":false,"acquired":true,"shares":4861,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":41745.46,"source":{"system":"sec-edgar","filing":"0001821825-25-000018","document":"wk-form4_1743630240.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1744046/000182182525000018/wk-form4_1743630240.xml","form_type":"4"}},{"id":1182408,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":54171,"kind":"person","name":"Karp Daniel","position":1,"cik":"0001744046","reported_name":"Karp Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP, Corp. Dev."}}],"security":"Common Stock","published_at":"2025-04-02T17:44:06.000Z","date":"2025-03-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":3554,"price":14.51,"value":51568.54,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This price is the closing market price of Organon & Co. (\"Organon\") common stock on Friday, March 28, 2025, as required by the plan under which the Restricted Stock Units (\"RSU\") were awarded."}],"balance_after":36884.46,"source":{"system":"sec-edgar","filing":"0001821825-25-000018","document":"wk-form4_1743630240.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1744046/000182182525000018/wk-form4_1743630240.xml","form_type":"4"}},{"id":1182407,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":54171,"kind":"person","name":"Karp Daniel","position":1,"cik":"0001744046","reported_name":"Karp Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP, Corp. Dev."}}],"security":"Common Stock","published_at":"2025-04-02T17:44:06.000Z","date":"2025-03-31","kind":"exercise","planned":false,"acquired":true,"shares":11338,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":40438.46,"source":{"system":"sec-edgar","filing":"0001821825-25-000018","document":"wk-form4_1743630240.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1744046/000182182525000018/wk-form4_1743630240.xml","form_type":"4"}},{"id":1182406,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":54171,"kind":"person","name":"Karp Daniel","position":1,"cik":"0001744046","reported_name":"Karp Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP, Corp. Dev."}}],"security":"Common Stock","published_at":"2025-04-02T17:44:06.000Z","date":"2025-03-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":4446,"price":14.51,"value":64511.46,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This price is the closing market price of Organon & Co. (\"Organon\") common stock on Friday, March 28, 2025, as required by the plan under which the Restricted Stock Units (\"RSU\") were awarded."}],"balance_after":29100.46,"source":{"system":"sec-edgar","filing":"0001821825-25-000018","document":"wk-form4_1743630240.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1744046/000182182525000018/wk-form4_1743630240.xml","form_type":"4"}},{"id":1182405,"issuer":{"id":4115,"kind":"organization","name":"Organon & Co."},"owners":[{"id":54171,"kind":"person","name":"Karp Daniel","position":1,"cik":"0001744046","reported_name":"Karp Daniel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP, Corp. Dev."}}],"security":"Common Stock","published_at":"2025-04-02T17:44:06.000Z","date":"2025-03-31","kind":"exercise","planned":false,"acquired":true,"shares":14184,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":33546.46,"source":{"system":"sec-edgar","filing":"0001821825-25-000018","document":"wk-form4_1743630240.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1744046/000182182525000018/wk-form4_1743630240.xml","form_type":"4"}},{"id":3272155,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":54171,"kind":"person","name":"Karp Daniel","position":1,"cik":"0001744046","reported_name":"Karp Daniel","relationship":{"officer":true,"officer_title":"EVP, Corporate Development"}}],"security":"Restricted Stock Unit","published_at":"2020-02-14T23:36:19.000Z","date":"2020-02-12","kind":"grant","acquired":true,"shares":6030,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":6030,"derivative":{"exercise_price":0,"expiration_date":"2023-02-12","underlying":"Common Stock","underlying_shares":6030},"source":{"system":"sec-edgar","filing":"0001127602-20-005781","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220005781/form4.xml","form_type":"4"}},{"id":3272154,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":54171,"kind":"person","name":"Karp Daniel","position":1,"cik":"0001744046","reported_name":"Karp Daniel","relationship":{"officer":true,"officer_title":"EVP, Corporate Development"}}],"security":"Restricted Stock Unit","published_at":"2020-02-14T23:36:19.000Z","date":"2020-02-12","kind":"other","acquired":false,"shares":1126,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number of shares that vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":4174,"derivative":{"exercise_price":0,"expiration_date":"2022-02-12","underlying":"Common Stock","underlying_shares":1126},"source":{"system":"sec-edgar","filing":"0001127602-20-005781","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220005781/form4.xml","form_type":"4"}},{"id":3272153,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":54171,"kind":"person","name":"Karp Daniel","position":1,"cik":"0001744046","reported_name":"Karp Daniel","relationship":{"officer":true,"officer_title":"EVP, Corporate Development"}}],"security":"Restricted Stock Unit","published_at":"2020-02-14T23:36:19.000Z","date":"2020-02-12","kind":"exercise","acquired":false,"shares":960,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":5300,"derivative":{"exercise_price":0,"expiration_date":"2022-02-12","underlying":"Common Stock","underlying_shares":960},"source":{"system":"sec-edgar","filing":"0001127602-20-005781","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220005781/form4.xml","form_type":"4"}},{"id":3272152,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":54171,"kind":"person","name":"Karp Daniel","position":1,"cik":"0001744046","reported_name":"Karp Daniel","relationship":{"officer":true,"officer_title":"EVP, Corporate Development"}}],"security":"Common Stock","published_at":"2020-02-14T23:36:19.000Z","date":"2020-02-12","kind":"tax_withholding","acquired":false,"shares":294,"price":331.76,"value":97537.44,"ownership":{"direct":true},"balance_after":930.387,"source":{"system":"sec-edgar","filing":"0001127602-20-005781","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220005781/form4.xml","form_type":"4"}},{"id":3272151,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":54171,"kind":"person","name":"Karp Daniel","position":1,"cik":"0001744046","reported_name":"Karp Daniel","relationship":{"officer":true,"officer_title":"EVP, Corporate Development"}}],"security":"Common Stock","published_at":"2020-02-14T23:36:19.000Z","date":"2020-02-12","kind":"exercise","acquired":true,"shares":960,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1224.387,"source":{"system":"sec-edgar","filing":"0001127602-20-005781","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760220005781/form4.xml","form_type":"4"}},{"id":3467081,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":54171,"kind":"person","name":"Karp Daniel","position":1,"cik":"0001744046","reported_name":"Karp Daniel","relationship":{"officer":true,"officer_title":"EVP, Corporate Development"}}],"security":"Restricted Stock Unit","published_at":"2019-07-05T20:51:39.000Z","date":"2019-07-02","kind":"other","acquired":false,"shares":390,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date])."}],"balance_after":1174,"derivative":{"exercise_price":0,"expiration_date":"2021-07-02","underlying":"Common Stock","underlying_shares":390},"source":{"system":"sec-edgar","filing":"0001127602-19-024060","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760219024060/form4.xml","form_type":"4"}},{"id":3467080,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":54171,"kind":"person","name":"Karp Daniel","position":1,"cik":"0001744046","reported_name":"Karp Daniel","relationship":{"officer":true,"officer_title":"EVP, Corporate Development"}}],"security":"Restricted Stock Unit","published_at":"2019-07-05T20:51:39.000Z","date":"2019-07-02","kind":"exercise","acquired":false,"shares":196,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date])."}],"balance_after":1564,"derivative":{"exercise_price":0,"expiration_date":"2021-07-02","underlying":"Common Stock","underlying_shares":196},"source":{"system":"sec-edgar","filing":"0001127602-19-024060","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760219024060/form4.xml","form_type":"4"}},{"id":3467079,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":54171,"kind":"person","name":"Karp Daniel","position":1,"cik":"0001744046","reported_name":"Karp Daniel","relationship":{"officer":true,"officer_title":"EVP, Corporate Development"}}],"security":"Common Stock","published_at":"2019-07-05T20:51:39.000Z","date":"2019-07-02","kind":"tax_withholding","acquired":false,"shares":58,"price":236.37,"value":13709.46,"ownership":{"direct":true},"balance_after":264.387,"source":{"system":"sec-edgar","filing":"0001127602-19-024060","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760219024060/form4.xml","form_type":"4"}},{"id":3467078,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":54171,"kind":"person","name":"Karp Daniel","position":1,"cik":"0001744046","reported_name":"Karp Daniel","relationship":{"officer":true,"officer_title":"EVP, Corporate Development"}}],"security":"Common Stock","published_at":"2019-07-05T20:51:39.000Z","date":"2019-07-02","kind":"exercise","acquired":true,"shares":196,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 20.653 shares acquired under the Biogen Inc. Employee Stock Purchase Plan on 9/28/2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 23.683 shares acquired under the Biogen Inc. Employee Stock Purchase Plan on 12/31/2019."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 82.051 shares acquired under the Biogen Inc. Employee Stock Purchase Plan on 3/29/2019."}],"balance_after":322.387,"source":{"system":"sec-edgar","filing":"0001127602-19-024060","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760219024060/form4.xml","form_type":"4"}},{"id":3658371,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":54171,"kind":"person","name":"Karp Daniel","position":1,"cik":"0001744046","reported_name":"Karp Daniel","relationship":{"officer":true,"officer_title":"EVP, Corporate Development"}}],"security":"Restricted Stock Unit","published_at":"2019-02-14T23:13:30.000Z","date":"2019-02-12","kind":"grant","acquired":true,"shares":6260,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":6260,"derivative":{"exercise_price":0,"expiration_date":"2022-02-12","underlying":"Common Stock","underlying_shares":6260},"source":{"system":"sec-edgar","filing":"0001127602-19-006084","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760219006084/form4.xml","form_type":"4"}},{"id":3877058,"issuer":{"id":1675,"kind":"organization","name":"BIOGEN INC.","symbol":"BIIB"},"owners":[{"id":54171,"kind":"person","name":"Karp Daniel","position":1,"cik":"0001744046","reported_name":"Karp Daniel","relationship":{"officer":true,"officer_title":"EVP, Corporate Development"}}],"security":"Restricted Stock Unit","published_at":"2018-07-03T20:21:30.000Z","date":"2018-07-02","kind":"grant","acquired":true,"shares":1760,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price following and including the grant date])."}],"balance_after":1760,"derivative":{"exercise_price":0,"expiration_date":"2021-07-02","underlying":"Common Stock","underlying_shares":1760},"source":{"system":"sec-edgar","filing":"0001127602-18-022624","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875045/000112760218022624/form4.xml","form_type":"4"}}]}